Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Lam Research Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $385.0B | |
|---|---|---|
| Revenue (ttm) | 26.1B | |
| Net income (ttm) | 8.4B | |
| EPS (ttm) | $6.71 | |
| Shares out | 1.2B | |
| P/E (trailing) | 37.8x | |
| P/E (forward) | 31.6x | |
| Dividend | $1.32 (0.52%) | |
| Volume | 7,833,740 | |
| Beta | 1.85 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $17.23B | $17.43B | $14.91B | $18.44B | $23.23B | +7.8% |
| Gross profit | $7.87B | $7.78B | $7.05B | $8.98B | $11.73B | +10.5% |
| Operating income | $5.38B | $5.30B | $4.55B | $5.96B | $8.26B | +11.3% |
| Net income | $4.61B | $4.51B | $3.83B | $5.36B | $7.27B | +12.1% |
| EPS (diluted) | $3.31 | $3.41 | $3.03 | $4.14 | $5.82 | +15.2% |
| EBITDA | $5.71B | $5.64B | $4.91B | $6.34B | $8.70B | +11.1% |
| R&D | $1.60B | $1.73B | $1.90B | $2.10B | $2.38B | +10.3% |
| SG&A | $885.7M | $832.8M | $868.2M | $981.7M | $1.15B | +6.7% |
Recent company headlines from major financial publishers.
The rebound is delivered, but support growth and process wins do not justify extending peak growth indefinitely.
More installed tools would support later service demand, while higher system volume would spread fixed costs across more sales. The case fades if those validation measures weaken.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 9.2% | $184 | $190 | $196 | $203 | $212 |
| 10.2% | $168 | $172 | $176 | $181 | $187 |
| 11.2% | $155 | $157 | $160 | $164 | $168 |
| 12.2% | $144 | $146 | $148 | $151 | $154 |
| 13.2% | $134 | $136 | $138 | $140 | $142 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |